CMV RLuc Reporter Lentivirus

The CMV RLuc reporter lentivirus is a versatile and highly efficient lentiviral vector engineered to express the Renilla luciferase (RLuc) gene under the control of the human cytomegalovirus (CMV) immediate-early promoter. This promoter ensures robust, constitutive expression of RLuc in a variety of mammalian cell types, making it an ideal tool for gene expression studies, signal transduction analysis, and high-throughput screening. The lentiviral backbone stably integrates into the host genome, enabling long-term gene expression in both dividing and non-dividing cells. Furthermore, the virus is pseudotyped with the vesicular stomatitis virus glycoprotein (VSV-G), which broadens its tropism and improves transduction efficiency in various cell lines and primary cells. To ensure biosafety, the vector is replication-competent and incorporates essential elements, including the packaging signal (Ψ), Rev response element (RRE), and woodchuck hepatitis virus posttranscriptional regulatory element (WPRE), for optimal transgene expression.

The CMV RLuc reporter lentivirus is widely used in biomedical research to monitor gene expression dynamics, assess promoter activity, and evaluate cellular responses to stimuli. The Renilla luciferase reporter system provides a sensitive, quantitative readout, enabling researchers to track changes in gene expression in real time using bioluminescence imaging or plate-based assays. This vector is particularly valuable for studying transcriptional regulation, as the stability of the CMV promoter ensures a high signal-to-noise ratio. In drug discovery, this virus is a key tool for high-throughput screening of compounds that modulate specific pathways or promoter activity. Furthermore, its ability to transduce difficult-to-transfect cells, such as neurons or immune cells, makes it an essential component of functional genomics and in vivo studies.